Resmed CFO Brett Sandercock to retire; Aaron Bloomer named successor starting May 2026

Resmed announced that Brett Sandercock, its Chief Financial Officer for 20 years, will retire effective May 4, 2026. Aaron Bloomer, formerly CFO at Exact Sciences, has been appointed as his successor. Bloomer brings over 17 years of global finance experience and a strong track record in driving growth and operational discipline. Sandercock will remain as an advisor to the CEO through 2027, while Resmed continues to execute its 2030 growth strategy.